Dimiter Angelov serves as the Dumbarton Oaks Professor of Byzantine History at Harvard University, holding a faculty position in the Department of History within the Faculty of Arts and Sciences. He chairs Harvard's Ph.D. Program in Byzantine Studies and teaches graduate and undergraduate courses spanning Byzantine, medieval eastern Mediterranean, and medieval Balkan history. His academic credentials include: Ph.D., Harvard University Professor Angelov specializes in the intellectual and political history of the Byzantine Empire after the tenth century, with focused interests in empire and imperialism, political thought and rhetoric, biography, geographical imagination, and the Fourth Crusade's impact. Current research encompasses a comprehensive history of Byzantine political thought examining virtue and tyranny from the fifth to fifteenth centuries, alongside collaborative analysis of Eustathios of Thessaloniki's twelfth-century geographical anthology. His scholarly output features three major monographs exploring Byzantine political ideology, court ceremonies, and imperial biography. These works demonstrate consistent engagement with thirteenth and fourteenth century institutional transformations, particularly how Byzantine elites navigated governance challenges through classical intellectual traditions in the post-Crusade era. No scientific awards are documented in the provided materials. He actively supervises graduate students pursuing research in Byzantine and medieval Balkan/eastern Mediterranean history. The source texts do not reference specific grants, funding sources, laboratory facilities, or research teams.
Joselyn Muhleisen serves as a Lecturer in the Department of Public Affairs at the Marxe School of Public and International Affairs, Baruch College, City University of New York. She teaches core courses including Citizenship and Public Affairs, Comprehensive Public Policy & Administration, and capstone seminars in Public and International Affairs, with active teaching assignments extending through Spring 2025. Her academic foundation includes: PhD in Political Science, The Graduate Center, CUNY (2016) MPhil in Political Science, The Graduate Center, CUNY MA in European Union International Relations and Diplomacy, College of Europe Brugge, Belgium BS in Public Affairs and English, Baruch College Dr. Muhleisen's research centers on international regimes, regulatory politics, and global governance , with specialized expertise in trade/financial regulation within transatlantic frameworks. Her scholarship critically examines EU-US regulatory convergence, Brexit's implications for global finance, and the institutional dynamics of international organizations. She has established herself as a leading voice in comparative policy analysis through foundational texts and systematic field reviews. Her 2016-2020 publications reveal a cohesive scholarly trajectory focused on advancing methodological rigor in comparative policy studies. The works collectively analyze historical evolution, theoretical frameworks, and cross-national applications of policy analysis, with particular emphasis on European and transatlantic contexts. This body of work demonstrates consistent engagement with both classical scholarship and contemporary developments in governance studies. Her honors include: Fulbright Study Grant to European Union (2007-2008) Getting to Know Europe Grant (European Commission) Doctoral Student Research Grant (2011) 23rd Street Scholarship for Excellence in Public Affairs (2007) Alfred Zweifach Award (2007) Colin Powell Fellowship (2007) Grant for Internship Travel to Romania (2005) USA Today Best and Brightest Nomination (2005) As Faculty Advisor since 2015, she mentors honors students and serves on multiple committees including the Excelsior Service Fellowship Committee and Undergraduate Honors Program Committee. Her grant portfolio features significant research funding including Fulbright and European Commission support for transatlantic regulatory studies. She actively contributes to academic governance through the Journal of Comparative Policy Analysis Award Committee and International Comparative Policy Analysis Forum leadership. She maintains active collaboration with the International Comparative Policy Analysis Forum as an officer and regularly presents at major conferences including the European Union Studies Association. Her research network includes prominent scholars like Iris Geva-May and Diane Hoffman, with ongoing projects examining post-Brexit financial governance structures.
Norman M. Naimark serves as the Robert & Florence McDonnell Professor of East European Studies and Professor of History at Stanford University, with courtesy appointments in German Studies. He holds senior fellowships at both the Hoover Institution and Freeman Spogli Institute for International Studies, and is affiliated with The Europe Center and the Center on Democracy, Development and the Rule of Law. Education: Ph.D. in History, Stanford University (1972) Naimark specializes in Soviet-era Eastern European history, with dual research pillars: Soviet policies in post-WWII Europe and 20th-century genocide/ethnic cleansing phenomena. His work bridges historical analysis with contemporary human rights discourse, emphasizing geopolitical power dynamics and systematic violence against civilian populations. Methodologically, he combines archival rigor with comparative frameworks across national contexts. His publication trajectory from 1979–2019 reveals evolving focus from Marxist movements in partitioned Poland to Soviet occupation mechanics, culminating in comprehensive genocide studies. The 2019 monograph on Stalin's postwar European sovereignty struggles synthesizes decades of research into Soviet imperial practices. Scientific awards: Officer's Cross of the Order of Merit of the Federal Republic of Germany (1996) Richard W. Lyman Award for outstanding faculty volunteer service (1995) Stanford Dean's Teaching Award (1991-92, 2002-3) Naimark's academic leadership includes directing Stanford's Global Studies Division, Bing Overseas Studies Program, and Center for Russian, East European, and Eurasian Studies. His research informs current policy discussions on authoritarianism and democratic resilience, as evidenced by recent engagements with Belarusian democracy movements and U.S.-Russia relations. He collaborates extensively through Stanford's interdisciplinary centers, particularly contributing historical perspectives to The Europe Center's sovereignty research and the Center on Democracy, Development and the Rule of Law's governance initiatives.
Emma Trentman is an Associate Professor of Arabic at the University of New Mexico (UNM) and Director of the Language Learning Center. Her research focuses on Applied Linguistics, particularly on language learning during study abroad programs, virtual exchange, and the impact of language ideologies on multilingual approaches. Research Interests: Multilingualism, Language Ideologies, Study Abroad Programs, Intercultural Communication, Arabic Language Education, and Curriculum Development. Key Publications: Co-editor of Language Learning in Study Abroad: The Multilingual Turn (2021), with works featured in The Modern Language Journal , Foreign Language Annals , and Critical Multilingualism Studies . Teaching: Offers Arabic language courses and the Languages Capstone class, integrating critical perspectives into language pedagogy. Editorial Work: Co-editor for Critical Multilingualism Studies Journal , advocating for plurilingual practices in education. Publications: Explores topics such as translanguaging, sociolinguistic competence, and decolonizing language learning frameworks across diverse contexts (Egypt, Tanzania, China). Advocacy: Engages in critical discussions on equity, identity, and sociocultural dimensions in language education.
University of California, Los AngelesUnited States
Julienne Bower is a Professor at the University of California, Los Angeles (UCLA) with joint appointments in the Department of Psychology and the Department of Psychiatry/Biobehavioral Sciences. She serves as Director of the Mind-Body Research Lab, Associate Director of the Cousins Center for Psychoneuroimmunology, and as a Member of the Jonsson Comprehensive Cancer Center. Her research explores mind-body interactions in individuals facing stressful life events, particularly cancer patients and survivors, focusing on biological pathways linking psychological states to health outcomes and the effects of mind-body interventions. Ph.D. from UCLA Area Chair: Health Psychology Primary Area: Health Psychology Secondary Area: Clinical Psychology Location: 6538 Pritzker Hall, UCLA Dr. Bower's research examines how positive psychological factors (e.g., benefit finding, positive affect) influence physical health through immune and neuroendocrine pathways, while also investigating mind-body interventions like yoga and mindfulness meditation. Her work spans observational, experimental, and intervention studies, emphasizing the immune system as a central mechanism. The Mind-Body Research Lab, under Dr. Bower's leadership, has published extensively on topics including cancer-related fatigue, stress-induced inflammation, and the physiological impacts of psychosocial interventions. Key publications address NF-κB signaling, glucocorticoid resistance, and cortisol dysregulation in cancer survivors. Dr. Bower's lab is actively recruiting graduate students for 2024 through the UCLA Health Psychology Program, offering training in psychoneuroimmunology, cancer prevention, and mind-body research methodologies.
Shahram Ghiasinejad is a Senior Lecturer in the Department of Psychology at the University of Central Florida (UCF), affiliated with the College of Sciences. He joined UCF in 2007 and specializes in education technology, student engagement, and equity in academic settings. Dr. Ghiasinejad holds a B.A. in Computer Science from the University of Texas at Austin, and an M.S. and Ph.D. in Cognition and Neuroscience from the University of Texas at Dallas. Bachelor of Arts: Computer Science, University of Texas at Austin Master of Science: Applied Cognition and Neuroscience, University of Texas at Dallas Doctor of Philosophy: Cognition and Neuroscience, University of Texas at Dallas His research focuses on leveraging experimental and computational methods to understand human language comprehension, alongside innovative approaches to support underrepresented students through multimedia tools and undergraduate research initiatives. Recent work emphasizes equity and engagement in higher education, including strategies for transfer students and first-generation learners. Publications highlight themes such as JoVE video integration for marginalized students, the role of undergraduate research in fostering equity, and creative solutions for academic challenges faced by underrepresented groups. While no formal awards are listed, his work underscores a commitment to inclusive education and student success.
Jonathan Winawer is an Associate Professor of Psychology and Neural Science at New York University (NYU). He leads the Winawer Laboratory for Human Visual Perception and Neuroscience, which is affiliated with the NYU Psychology Department, NYU Center for Neural Science, NYU Neuroscience Institute, and collaborates with the NYU Comprehensive Epilepsy Center and Stanford University's Human Intracranial Cognitive Program. Ph.D., Massachusetts Institute of Technology (2007) M.S., City College of the City University of New York (2005) A.B., Columbia University (1995) His research focuses on the biological basis of visual perception, including computational models of the visual pathways using fMRI, EEG, ECoG, and psychophysics. Key areas include: Encoding of visual stimuli in neural pathways Perceptual memory's influence on cognition Neural circuit properties underlying imaging signals Individual differences in visual perception Publications highlight interdisciplinary approaches spanning computational neuroscience, neuroimaging, and psychophysics, with recent work on population receptive fields, spatial frequency tuning, and memory-related cortical dynamics. He has mentored numerous students and postdocs, many of whom have advanced to academic and research roles at institutions like Stanford, Columbia, and the University of Amsterdam. Department of Psychology, NYU Center for Neural Science, NYU Neuroscience Institute, NYU Comprehensive Epilepsy Center, NYU Stanford University collaborations
Allison Ross Eckard, MD is Professor in the Departments of Pediatrics and Medicine at the Medical University of South Carolina (MUSC) College of Medicine, serving as Division Chief for Pediatric Infectious Diseases and Director of MUSC's Ryan White Pediatric HIV Clinic and HIV Transition Clinic. She maintains an adjunct faculty position at Emory University and holds board certification in Pediatrics and Pediatric Infectious Diseases. Her primary research focuses on metabolic, cardiovascular, and nutritional complications of chronic HIV and antiretroviral therapy across age groups, with emphasis on inflammation's role in comorbidities like cardiovascular disease and bone disorders. Current investigations include NIH R01-funded research on interventions for weight gain and abdominal fat in HIV, vitamin D supplementation, and statin therapy. She has published nearly 60 peer-reviewed papers on HIV pathogenesis and treatment optimization. Dr. Eckard co-chairs the DHHS panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children and serves on the DHHS panel for Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV . Her clinical work specializes in comprehensive HIV care for children through young adults, with particular focus on adolescent/young adult transition issues and global health initiatives through Lespwa Timoun in Haiti. Recent efforts include developing COVID-19 treatment guidelines for children and school safety protocols. HIV Specialist certification (American Academy of HIV Medicine) Fellow, Infectious Diseases Society of America Fellow, Pediatric Infectious Diseases Society Fellow, HIV Medical Association Member, HIV Medical Association's 'Ending the HIV Epidemic' working group She leads MUSC's HIV education initiatives and serves as inpatient consultant for pediatric infectious diseases, with advanced training in tropical medicine. Her NIH-funded research examines targeted interventions to minimize comorbidity development in HIV, while her clinical leadership spans the Ryan White HIV program, transition clinics, and global health partnerships.
Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.
Andrew Head is an Assistant Professor at the University of Pennsylvania in the Computer and Information Science department. His research focuses on human-computer interaction, programming, and reading, particularly in developing technology for interactive reading and reasoning. He advises PhD students Alyssa Hwang, Hita Kambhamettu, Litao Yan, Jeffrey Tao, and Jessica Shi, and co-leads the Penn Human-Computer Interaction (Penn HCI) group with Danaé Metaxa. His work is published in top venues like ACM CHI, UIST, and ICSE. Research Interests: Andrew's work bridges interactive systems with programming environments, aiming to enhance how scientists and programmers interact with their tools. Key areas include AI-assisted code understanding, math notation accessibility, and medical note interpretation through interactivity. He employs user studies to identify needs and builds interactive systems to address them. Recent Article Trends: His publications emphasize systems-centric HCI approaches, integrating AI into code and document interfaces. Topics span code explanation (e.g., Ivie), property-based testing (e.g., Tyche), math notation augmentation (e.g., FreeForm), and medical informatics (e.g., Explainable Notes). Recent work also explores notebook environments (e.g., Bolt-on, Tyche) and literate programming (e.g., Colaroid). Scientific Awards: Distinguished Paper Award, ICSE 2024 Best Paper Awards at CHI (2024, 2023, 2022, 2019), UIST (2023, 2018), and others. Nominated for Best Paper at CHI 2023 and VL/HCC 2015. Advising & Grants: Andrew advises multiple PhD students and has secured significant grants, including a $1M NSF award for 'Property-based Testing for the People' (2024). His group collaborates with Penn’s MindCORE center and teams like PLClub and PennNLP. Labs & Teams: He co-leads the Penn HCI group, which works closely with other Penn research teams and labs. The group focuses on creating interactive tools that enhance scientific and programming workflows, supported by grants and cross-institutional partnerships.
Gail E. Kaiser is a Professor of Computer Science and the Director of the Programming Systems Laboratory (PSL) in the Computer Science Department at Columbia University. She has been with Columbia University since 1985, becoming a full Professor in 1998. Prof. Kaiser's research spans software engineering, program analysis, software testing, and software security, with recent focus on addressing challenges in AI/ML systems testing and security. Prof. Kaiser received her PhD in Computer Science from Carnegie Mellon University in 1985 and her ScB in Computer Science and Engineering from MIT in 1979. Her dissertation at CMU was titled "Semantics for Structure Editing Environments" under advisor Nico Habermann, and at MIT she completed "Automatic Extension of an Augmented Transition Network Grammar for Morse Code Conversations" under advisor Al Vezza. Prof. Kaiser's research interests primarily focus on software engineering following a systems building approach, with recent emphasis on static and dynamic program analysis techniques to improve software reliability and security. Since 2005, she has investigated testing "non-testable" programs, particularly in machine learning, data mining, and scientific computing applications where traditional testing oracles are insufficient. She has developed novel techniques and tools for detecting bugs and verifying repairs in complex systems. Concurrently, she has worked on collaboration environments for computational scientists, creating knowledge sharing and domain-aware environments to support scientific workflows. Prof. Kaiser's recent publications demonstrate a strong focus on the intersection of software engineering and artificial intelligence. Her work addresses critical challenges in testing AI systems, code understanding through deep learning, vulnerability detection, and educational tools for computational thinking. There's a clear evolution from traditional software engineering topics toward AI/ML applications, with particular emphasis on metamorphic testing for non-testable systems, code similarity analysis, and educational applications. Prof. Kaiser has received numerous prestigious awards throughout her career: Distinguished Journal Award (10 Years) from 18th IEEE International Conference on Software Testing, Verification and Validation (ICST), April 2025 Best Research Paper Award at 24th IEEE International Conference on Source Code Analysis & Manipulation (SCAM), October 2024 Distinguished Reviewer Awards for ASE 2024 and FSE 2024 ACM SIGSOFT Distinguished Paper Award for "CONCORD: Clone-aware Contrastive Learning for Source Code", July 2023 Best Student Paper Award at ICCE 2021 Multiple ACM SIGSOFT Distinguished Paper Awards dating back to 2014 Presidential Young Investigator in Software Engineering and Software Systems from NSF (1988-1993) Prof. Kaiser has chaired Columbia's doctoral program since 1997 and served on editorial boards including IEEE Internet Computing and as a founding associate editor of ACM Transactions on Software Engineering and Methodology. Her lab has been continuously funded by major agencies including NSF, NIH, DARPA, ONR, NASA, and numerous companies. Current grants include significant NSF funding for secure containers architecture, learning semantics of code for software assurance, and finding semantic security bugs. As Director of the Programming Systems Laboratory (PSL), Prof. Kaiser leads research in software systems, program analysis, and software testing. The lab has developed numerous tools and techniques for software reliability and security, with recent focus on challenges in AI/ML systems. Her work bridges theoretical foundations with practical applications, often resulting in deployable tools that address real-world software engineering challenges.
Mayo Clinic College of Medicine and ScienceUnited States
Mark R. Pittelkow is a Professor of Dermatology at the Mayo Clinic, holding a primary appointment as a Consultant in the Department of Dermatology. He completed his MD at Mayo Medical School and advanced training through Mayo Graduate School of Medicine and Northwestern University. His research focuses on cutaneous lymphomas, photoprotection, and skin cancer, with leadership roles in international guidelines (ISCL/EORTC). He contributes to clinical trials, medical education, and interdisciplinary research through affiliations like the Mayo Clinic Comprehensive Cancer Center and Regenerative Biotherapeutics. Education: MD (Mayo Medical School), MS (Biological Sciences, Northwestern), BA (Northwestern University). Research spans cutaneous lymphoma classification, immunology, and translational dermatology. Notable publications address staging systems for mycosis fungoides/Sezary syndrome and photoprotection strategies. His work integrates clinical practice with molecular mechanisms, such as JAK inhibitor responses in lichen planus. Labs/Teams: Collaborates with Mayo Clinic Cancer Center and interdisciplinary groups in immunotherapy and regenerative medicine. Supervises clinical trials and postdoctoral training programs.
Cherie Kagan serves as the Stephen J. Angello Professor at the University of Pennsylvania, holding primary appointment in the Department of Electrical and Systems Engineering within the School of Engineering and Applied Science, with secondary appointments in Chemistry and Materials Science and Engineering. Her interdisciplinary research bridges chemistry, materials science, and electrical engineering to develop novel functional materials and devices that integrate optical, electrical, magnetic, mechanical, and thermal properties. Professor Kagan's research group combines the flexibility of chemical synthesis and bottom-up assembly with top-down fabrication techniques to design innovative nanomaterials. They employ advanced characterization methods including spatially- and temporally-resolved optical spectroscopies, AC/DC electrical measurements, electrochemistry, and various microscopy techniques. Her recent work demonstrates particular strength in colloidal nanocrystals and quantum dots for applications in quantum information science, sensing technologies, and energy conversion devices. Scientific Recognition Induction to the American Academy of Arts and Sciences (2025) IEEE Fellow (2024) for contributions to colloidal nanocrystals and their integration in optical and electronic devices George H. Heilmeier Faculty Award for Excellence in Engineering (2024-25) Humboldt Research Award Fellowship (2024) MRS Fellow for distinguished research accomplishments in materials science National Academy of Inventors Fellow for innovation in nanomaterials Professor Kagan actively mentors PhD students across multiple departments, with recent graduates including Gary Chen, Chavez Lawrence, and Shobhita Kramadhati. Her research is supported by significant grants including the IoT4Ag project focused on precision agriculture sensing systems. She maintains active collaborations with Nobel Laureate Moungi Bawendi, her former PhD advisor at MIT, and works with institutions including the Max-Planck Institute for Chemical Physics of Solids through her Humboldt Fellowship. The Kagan Research Group operates comprehensive facilities for nanomaterials synthesis, characterization, and device fabrication, combining expertise across chemistry, physics, and engineering disciplines. Current team members include PhD students from Electrical and Systems Engineering and Chemistry departments, postdoctoral researchers like Anamika Singh and Akhila Mallavarapu, and undergraduate researchers supported through programs like CURF.
Weiping Tang is a Professor of Pharmaceutical Sciences and Chemistry at the University of Wisconsin-Madison, holding the Janis Apinis Professorship in the School of Pharmacy and the Vilas Distinguished Achievement Professorship. He also serves as Director of the Medicinal Chemistry Center at the School of Pharmacy and maintains a faculty appointment with the Department of Chemistry in the College of Letters and Science. Janis Apinis Professor of Pharmaceutical Sciences Vilas Distinguished Achievement Professor Director of Medicinal Chemistry Center Faculty Appointment with Department of Chemistry Dr. Tang received his B.S. in Chemistry from Peking University in 1997, M.S. in Chemistry from New York University in 1999, Ph.D. in Organic Chemistry from Stanford University in 2005, and completed a postdoctoral fellowship in Medicinal Chemistry, Chemical Biology and Drug Discovery at Harvard University in 2007. Dr. Tang's research program focuses on drug discovery for cancer, infectious diseases, and neurodegenerative disorders through three interconnected areas: Organic Synthesis (advancing glycoscience through novel carbohydrate synthesis technologies), Medicinal Chemistry (developing small molecules that selectively remove disease-associated proteins), and Chemical Biology (dissecting biological pathways using novel small molecule probes). His group operates as an interdisciplinary team where chemists and biologists collaborate closely on drug discovery projects, with particular emphasis on developing novel degraders for disease-causing proteins. Analysis of Dr. Tang's publication record reveals a significant shift toward targeted protein degradation technologies, particularly PROTACs and molecular glues, while maintaining strong foundations in carbohydrate chemistry. His most impactful recent work includes developing degraders for extracellular and membrane proteins (previously considered 'undruggable'), creating rapid synthesis platforms like Rapid-TAC and Rapid-Glue, and advancing understanding of ternary complex formation for novel PROTAC design. His research spans both chemical methodology development and therapeutic applications across multiple disease areas. Vilas Distinguished Achievement Professorship Janis Apinis Professorship Numerous high-impact publications in leading chemistry and pharmacology journals Editor's pick and hot paper designations for significant contributions Dr. Tang mentors a diverse team of graduate students, postdoctoral fellows, and staff scientists with expertise spanning synthetic chemistry, medicinal chemistry, carbohydrate chemistry, computational chemistry, biochemistry, and cell biology. His group has developed innovative platforms for the rapid synthesis of protein degraders and has made significant contributions to understanding the mechanisms of action for these novel therapeutics. Current research includes developing selective degraders for cancer targets like RIPK1, BRD4, and CARM1, as well as advancing delivery systems for clinical translation. The Tang Research Group maintains state-of-the-art facilities within the School of Pharmacy at UW-Madison, equipped for comprehensive chemical synthesis, compound characterization, and biological evaluation. The group actively collaborates with researchers across campus and with industry partners to advance discoveries toward clinical applications, with particular focus on cancer therapeutics and protein degradation technologies.
Dr. Birgit Frauscher is the Lincoln Financial Group Distinguished Professor in Neurobiology at Duke University School of Medicine, where she serves as Professor of Neurology and holds a secondary appointment in the Department of Biomedical Engineering at the Duke Pratt School of Engineering. She is currently the Director of the Duke Comprehensive Epilepsy Center and leads the Analytical Neurophysiology (ANPHY) Lab. Her clinical and research work focuses on epilepsy and sleep medicine, utilizing both invasive and non-invasive electrical recordings to study brain activity in humans. Dr. Frauscher completed her medical training, neurology residency, and subspecialty training in electroencephalography, epilepsy, and sleep medicine at the Medical University of Innsbruck in Austria. After completing her clinical training in 2008, she earned her habilitation degree in 2011. She further specialized in intracranial EEG and signal analysis during a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University (2013-2015), where she later served as an Attending Epileptologist and Group Leader of Epilepsy. Her research interests focus on developing novel seizure-independent EEG markers for the epileptogenic zone, investigating sleep-epilepsy interactions, and using intracranial EEG to study brain physiology during wakefulness and sleep. Her work aims to improve epilepsy diagnosis, prognosis, and treatment outcomes by better localizing the epileptic focus. Dr. Frauscher's recent publications demonstrate her continued leadership in epilepsy research, with over 170 peer-reviewed papers and an H-index of 62. Dr. Frauscher has received several prestigious awards including the Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015). Her scholarly work has significantly advanced clinical knowledge in epilepsy and sleep medicine, establishing her as a leading figure in the field. As Director of the Duke Comprehensive Epilepsy Center and head of the ANPHY lab, Dr. Frauscher oversees a research program dedicated to advancing neuroscience through innovative approaches to studying brain activity. Her lab employs quantifiable tools to investigate neurophysiological and pathological processes related to epilepsy and sleep, with the ultimate goal of improving patient outcomes through better understanding of brain function.
